{"company":{"id":3787119,"name":"Syenex","domain":"syenex.com","url":"https://alion.io/company/syenex"},"answer":"As of Nov 17, 2026, Alion lists 10 companies most like Syenex: Addition Therapeutics, 4D Molecular Therapeutics, Krystal Biotech, ElevateBio, Capricor Therapeutics, Inc., Rejuvenate Bio, Eyescreen, Inc., Code Biotherapeutics, Profluent and eGenesis.","highlights":["Syenex itself has 7 open roles on Alion.","Of them, 4D Molecular Therapeutics is hiring the most, with 19 open roles.","ElevateBio has raised the most venture funding on record: $525M."],"as_of":"2026-11-17","cite":"Alion, \"Syenex competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 17, 2026. https://alion.io/company/syenex/competitors","indexable":true,"target":{"name":"Syenex","url":"https://alion.io/company/syenex","domain":"syenex.com","open_roles":7,"open_roles_change":null,"funding":{"total_raised_usd":13662428,"last_round":"venture","last_round_usd":8662428,"last_round_date":"2025-01-13","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Evanston","country":"US"},"technologies":["GMP","Cell Culture","Flow Cytometry"],"hiring_countries":["US"],"similarity":null},"competitors":[{"name":"Addition Therapeutics","url":"https://alion.io/company/additiontx","domain":"additiontx.com","open_roles":3,"open_roles_change":null,"funding":{"total_raised_usd":100000000,"last_round":"venture","last_round_usd":100000000,"last_round_date":"2025-12-17","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"South San Francisco","country":"US"},"technologies":["Python","Flow Cytometry","ELISA"],"hiring_countries":["US"],"similarity":{"score":14.75,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["qPCR","Flow Cytometry","ELISA","Western Blot","Cell Culture"],"same_hq_country":true}},{"name":"4D Molecular Therapeutics","url":"https://alion.io/company/4dmoleculartherapeutics","domain":"4dmoleculartherapeutics.com","open_roles":19,"open_roles_change":null,"funding":{"total_raised_usd":89999874,"last_round":"venture","last_round_usd":89999874,"last_round_date":"2018-08-27","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Emeryville","country":"US"},"technologies":["GCP","CAPA","Microsoft Excel"],"hiring_countries":["US"],"similarity":{"score":14.25,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["qPCR","ELISA","Cell Culture","Molecular Cloning","GMP"],"same_hq_country":true}},{"name":"Krystal Biotech","url":"https://alion.io/company/krystalbio","domain":"krystalbio.com","open_roles":8,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Pittsburgh","country":"US"},"technologies":["GMP","GCP","Veeva"],"hiring_countries":["US"],"similarity":{"score":14.25,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["qPCR","ELISA","Western Blot","Cell Culture","GMP"],"same_hq_country":true}},{"name":"ElevateBio","url":"https://alion.io/company/elevate-bio","domain":"elevate.bio","open_roles":11,"open_roles_change":null,"funding":{"total_raised_usd":525000000,"last_round":"venture","last_round_usd":525000000,"last_round_date":"2021-03-15","lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Waltham","country":"US"},"technologies":["GMP","CAPA","Flow Cytometry"],"hiring_countries":["US"],"similarity":{"score":13.2,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["Machine Learning","CRISPR","qPCR","Flow Cytometry","ELISA"],"same_hq_country":true}},{"name":"Capricor Therapeutics, Inc.","url":"https://alion.io/company/capricor","domain":"capricor.com","open_roles":11,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Beverly Hills","country":"US"},"technologies":["GMP","CAPA","Power BI"],"hiring_countries":["US"],"similarity":{"score":12.7,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["Flow Cytometry","Cell Culture","GMP"],"same_hq_country":true}},{"name":"Rejuvenate Bio","url":"https://alion.io/company/rejuvenatebio","domain":"rejuvenatebio.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":34046354,"last_round":"venture","last_round_usd":19471354,"last_round_date":"2026-06-03","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"San Diego","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":12.5,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":true}},{"name":"Eyescreen, Inc.","url":"https://alion.io/company/eyescreenlab","domain":"eyescreenlab.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Salt Lake City","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":12.5,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":true}},{"name":"Code Biotherapeutics","url":"https://alion.io/company/code-biotherapeutics","domain":"codebiotx.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Hatfield","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":12.5,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":[],"same_hq_country":true}},{"name":"Profluent","url":"https://alion.io/company/profluent","domain":"profluent.bio","open_roles":12,"open_roles_change":null,"funding":{"total_raised_usd":149000000,"last_round":"venture","last_round_usd":106000000,"last_round_date":"2025-11-21","lead_investors":["Spark Capital"]},"size_band":"51-200","headquarters":{"city":"Berkeley","country":"US"},"technologies":["Machine Learning","GCP","PyTorch"],"hiring_countries":["US"],"similarity":{"score":12.35,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["Machine Learning","CRISPR","Flow Cytometry","Cell Culture"],"same_hq_country":true}},{"name":"eGenesis","url":"https://alion.io/company/egenesis","domain":"egenesis.com","open_roles":9,"open_roles_change":null,"funding":{"total_raised_usd":239618354,"last_round":"venture","last_round_usd":124999955,"last_round_date":"2021-02-26","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Cambridge","country":"US"},"technologies":["GCP","GMP","Flow Cytometry"],"hiring_countries":["US"],"similarity":{"score":12.25,"shared_segments":["Cell & Gene Therapy"],"shared_technologies":["qPCR","Flow Cytometry","ELISA","Cell Culture","GMP"],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/syenex/competitors","json_url":"https://alion.io/company/syenex/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-17T02:50:30Z","generated_at":"2026-11-17T22:32:38Z"}}